Oncology & Cancer

Bevacizumab ovarian cancer trial: Real-world impact?

A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...

page 3 from 40